Compile Data Set for Download or QSAR
Report error Found 58 Enz. Inhib. hit(s) with all data for entry = 6977
TargetCannabinoid receptor 2(Human)
Allergan

US Patent
LigandChemical structure of BindingDB Monomer ID 163050BDBM163050(US9062004, 13)
Affinity DataIC50: 4.80nMAssay Description:Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 .mu.mol/mg protein, receptor co...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/9/2016
Entry Details
US Patent

TargetCannabinoid receptor 2(Human)
Allergan

US Patent
LigandChemical structure of BindingDB Monomer ID 163042BDBM163042(US9062004, 5 | US9670216, 13 4-Bromo-5-propylamino...)
Affinity DataIC50: 5.40nMAssay Description:Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 .mu.mol/mg protein, receptor co...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/9/2016
Entry Details
US Patent

TargetCannabinoid receptor 2(Human)
Allergan

US Patent
LigandChemical structure of BindingDB Monomer ID 163069BDBM163069(US9062004, 36 | US9670216, 36 1-(2-Morpholin-4-yle...)
Affinity DataIC50: 8.5nMAssay Description:Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 .mu.mol/mg protein, receptor co...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/9/2016
Entry Details
US Patent

TargetCannabinoid receptor 2(Human)
Allergan

US Patent
LigandChemical structure of BindingDB Monomer ID 163041BDBM163041(US9062004, 4 | US9670216, 4 4-Chloro-5-dimethylami...)
Affinity DataIC50: 17nMAssay Description:Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 .mu.mol/mg protein, receptor co...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/9/2016
Entry Details
US Patent

TargetCannabinoid receptor 2(Human)
Allergan

US Patent
LigandChemical structure of BindingDB Monomer ID 163067BDBM163067(US9062004, 34 | US9670216, 34 1-Propyl-5-(3,3,5,5-...)
Affinity DataIC50: 17nMAssay Description:Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 .mu.mol/mg protein, receptor co...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/9/2016
Entry Details
US Patent

TargetCannabinoid receptor 2(Human)
Allergan

US Patent
LigandChemical structure of BindingDB Monomer ID 163065BDBM163065(US9062004, 31 | US9670216, 32 4-Chloro-5-(2-diethy...)
Affinity DataIC50: 20nMAssay Description:Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 .mu.mol/mg protein, receptor co...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/9/2016
Entry Details
US Patent

TargetCannabinoid receptor 2(Human)
Allergan

US Patent
LigandChemical structure of BindingDB Monomer ID 163051BDBM163051(US9062004, 15 | US9670216, 16 4-Chloro-2-(3,5-dime...)
Affinity DataIC50: 22.4nMAssay Description:Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 .mu.mol/mg protein, receptor co...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/9/2016
Entry Details
US Patent

TargetCannabinoid receptor 2(Human)
Allergan

US Patent
LigandChemical structure of BindingDB Monomer ID 50005908BDBM50005908(CHEMBL3234707 | US9062004, 14 | US9670216, 14 4-Br...)
Affinity DataIC50: 42nMAssay Description:Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 .mu.mol/mg protein, receptor co...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/9/2016
Entry Details
US Patent

TargetCannabinoid receptor 2(Human)
Allergan

US Patent
LigandChemical structure of BindingDB Monomer ID 163045BDBM163045(US9062004, 8 | US9670216, 8 5-Propylamino-2-(3,3,5...)
Affinity DataIC50: 68nMAssay Description:Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 .mu.mol/mg protein, receptor co...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/9/2016
Entry Details
US Patent

TargetCannabinoid receptor 2(Human)
Allergan

US Patent
LigandChemical structure of BindingDB Monomer ID 163048BDBM163048(US9062004, 11 | US9670216, 11 4-Chloro-5-(2-morpho...)
Affinity DataIC50: 83nMAssay Description:Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 .mu.mol/mg protein, receptor co...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/9/2016
Entry Details
US Patent

TargetCannabinoid receptor 2(Human)
Allergan

US Patent
LigandChemical structure of BindingDB Monomer ID 163071BDBM163071(US9062004, 38 | US9670216, 38 1-(2-Dimethylaminoet...)
Affinity DataIC50: 105nMAssay Description:Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 .mu.mol/mg protein, receptor co...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/9/2016
Entry Details
US Patent

TargetCannabinoid receptor 1(Human)
Allergan

US Patent
LigandChemical structure of BindingDB Monomer ID 163050BDBM163050(US9062004, 13)
Affinity DataIC50: 174nMAssay Description:Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 .mu.mol/mg protein, receptor co...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/9/2016
Entry Details
US Patent

TargetCannabinoid receptor 2(Human)
Allergan

US Patent
LigandChemical structure of BindingDB Monomer ID 163049BDBM163049(US9062004, 12 | US9670216, 12 4-Chloro-5-(2-dimeth...)
Affinity DataIC50: 204nMAssay Description:Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 .mu.mol/mg protein, receptor co...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/9/2016
Entry Details
US Patent

TargetCannabinoid receptor 1(Human)
Allergan

US Patent
LigandChemical structure of BindingDB Monomer ID 163069BDBM163069(US9062004, 36 | US9670216, 36 1-(2-Morpholin-4-yle...)
Affinity DataIC50: 219nMAssay Description:Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 .mu.mol/mg protein, receptor co...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/9/2016
Entry Details
US Patent

TargetCannabinoid receptor 2(Human)
Allergan

US Patent
LigandChemical structure of BindingDB Monomer ID 163068BDBM163068(US9062004, 35 | US9670216, 35 2-Propyl-5-(3,3,5,5-...)
Affinity DataIC50: 240nMAssay Description:Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 .mu.mol/mg protein, receptor co...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/9/2016
Entry Details
US Patent

TargetCannabinoid receptor 1(Human)
Allergan

US Patent
LigandChemical structure of BindingDB Monomer ID 163067BDBM163067(US9062004, 34 | US9670216, 34 1-Propyl-5-(3,3,5,5-...)
Affinity DataIC50: 257nMAssay Description:Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 .mu.mol/mg protein, receptor co...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/9/2016
Entry Details
US Patent

TargetCannabinoid receptor 2(Human)
Allergan

US Patent
LigandChemical structure of BindingDB Monomer ID 163040BDBM163040(US9062004, 3 | US9670216, 3 4-Chloro-5-methylamino...)
Affinity DataIC50: 355nMAssay Description:Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 .mu.mol/mg protein, receptor co...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/9/2016
Entry Details
US Patent

TargetCannabinoid receptor 2(Human)
Allergan

US Patent
LigandChemical structure of BindingDB Monomer ID 163044BDBM163044(US9062004, 7 | US9670216, 7 5-Dimethylamino-2-(3,3...)
Affinity DataIC50: 380nMAssay Description:Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 .mu.mol/mg protein, receptor co...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/9/2016
Entry Details
US Patent

TargetCannabinoid receptor 2(Human)
Allergan

US Patent
LigandChemical structure of BindingDB Monomer ID 163039BDBM163039(US9062004, 2 | US9670216, 2 4,5-Dichloro-2-(3,3,5,...)
Affinity DataIC50: 389nMAssay Description:Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 .mu.mol/mg protein, receptor co...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/9/2016
Entry Details
US Patent

TargetCannabinoid receptor 1(Human)
Allergan

US Patent
LigandChemical structure of BindingDB Monomer ID 163041BDBM163041(US9062004, 4 | US9670216, 4 4-Chloro-5-dimethylami...)
Affinity DataIC50: 1.02E+3nMAssay Description:Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 .mu.mol/mg protein, receptor co...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/9/2016
Entry Details
US Patent

TargetCannabinoid receptor 1(Human)
Allergan

US Patent
LigandChemical structure of BindingDB Monomer ID 163042BDBM163042(US9062004, 5 | US9670216, 13 4-Bromo-5-propylamino...)
Affinity DataIC50: 1.02E+3nMAssay Description:Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 .mu.mol/mg protein, receptor co...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/9/2016
Entry Details
US Patent

TargetCannabinoid receptor 2(Human)
Allergan

US Patent
LigandChemical structure of BindingDB Monomer ID 163066BDBM163066(US9062004, 32)
Affinity DataIC50: 1.29E+3nMAssay Description:Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 .mu.mol/mg protein, receptor co...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/9/2016
Entry Details
US Patent

TargetCannabinoid receptor 2(Human)
Allergan

US Patent
LigandChemical structure of BindingDB Monomer ID 163070BDBM163070(US9062004, 37 | US9670216, 37 2-(2-Morpholin-4-yle...)
Affinity DataIC50: 1.51E+3nMAssay Description:Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 .mu.mol/mg protein, receptor co...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/9/2016
Entry Details
US Patent

TargetCannabinoid receptor 2(Human)
Allergan

US Patent
LigandChemical structure of BindingDB Monomer ID 163038BDBM163038(US9670216, 13 5-hydroxy-2-(3,3,5,5-tetramethylcycl...)
Affinity DataIC50: 1.82E+3nMAssay Description:Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 .mu.mol/mg protein, receptor co...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/9/2016
Entry Details
US Patent

TargetCannabinoid receptor 1(Human)
Allergan

US Patent
LigandChemical structure of BindingDB Monomer ID 163051BDBM163051(US9062004, 15 | US9670216, 16 4-Chloro-2-(3,5-dime...)
Affinity DataIC50: 1.86E+3nMAssay Description:Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 .mu.mol/mg protein, receptor co...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/9/2016
Entry Details
US Patent

TargetCannabinoid receptor 2(Human)
Allergan

US Patent
LigandChemical structure of BindingDB Monomer ID 163072BDBM163072(US9062004, 39 | US9670216, 39 2-(2-Dimethylaminoet...)
Affinity DataIC50: 2.04E+3nMAssay Description:Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 .mu.mol/mg protein, receptor co...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/9/2016
Entry Details
US Patent

TargetCannabinoid receptor 2(Human)
Allergan

US Patent
LigandChemical structure of BindingDB Monomer ID 163043BDBM163043(US9062004, 6 | US9670216, 6 5-Methylamino-2-(3,3,5...)
Affinity DataIC50: 2.09E+3nMAssay Description:Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 .mu.mol/mg protein, receptor co...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/9/2016
Entry Details
US Patent

TargetCannabinoid receptor 1(Human)
Allergan

US Patent
LigandChemical structure of BindingDB Monomer ID 163065BDBM163065(US9062004, 31 | US9670216, 32 4-Chloro-5-(2-diethy...)
Affinity DataIC50: 2.63E+3nMAssay Description:Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 .mu.mol/mg protein, receptor co...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/9/2016
Entry Details
US Patent

TargetCannabinoid receptor 1(Human)
Allergan

US Patent
LigandChemical structure of BindingDB Monomer ID 163071BDBM163071(US9062004, 38 | US9670216, 38 1-(2-Dimethylaminoet...)
Affinity DataIC50: 3.98E+3nMAssay Description:Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 .mu.mol/mg protein, receptor co...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/9/2016
Entry Details
US Patent

TargetCannabinoid receptor 1(Human)
Allergan

US Patent
LigandChemical structure of BindingDB Monomer ID 163048BDBM163048(US9062004, 11 | US9670216, 11 4-Chloro-5-(2-morpho...)
Affinity DataIC50: 3.98E+3nMAssay Description:Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 .mu.mol/mg protein, receptor co...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/9/2016
Entry Details
US Patent

TargetCannabinoid receptor 1(Human)
Allergan

US Patent
LigandChemical structure of BindingDB Monomer ID 50005908BDBM50005908(CHEMBL3234707 | US9062004, 14 | US9670216, 14 4-Br...)
Affinity DataIC50: 7.41E+3nMAssay Description:Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 .mu.mol/mg protein, receptor co...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/9/2016
Entry Details
US Patent

TargetCannabinoid receptor 2(Human)
Allergan

US Patent
LigandChemical structure of BindingDB Monomer ID 163046BDBM163046(US9062004, 9 | US9670216, 9 4-Chloro-2-phenyl-5-pr...)
Affinity DataIC50: 1.00E+4nMAssay Description:Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 .mu.mol/mg protein, receptor co...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/9/2016
Entry Details
US Patent

TargetCannabinoid receptor 2(Human)
Allergan

US Patent
LigandChemical structure of BindingDB Monomer ID 163047BDBM163047(US9062004, 10 | US9670216, 10 4-Chloro-2-cyclohexy...)
Affinity DataIC50: 1.00E+4nMAssay Description:Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 .mu.mol/mg protein, receptor co...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/9/2016
Entry Details
US Patent

TargetCannabinoid receptor 2(Human)
Allergan

US Patent
LigandChemical structure of BindingDB Monomer ID 163056BDBM163056(US9062004, 21 | US9670216, 21 2-(3,5-Bistrifluorom...)
Affinity DataIC50: 1.00E+4nMAssay Description:Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 .mu.mol/mg protein, receptor co...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/9/2016
Entry Details
US Patent

TargetCannabinoid receptor 2(Human)
Allergan

US Patent
LigandChemical structure of BindingDB Monomer ID 163057BDBM163057(US9062004, 22)
Affinity DataIC50: 1.00E+4nMAssay Description:Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 .mu.mol/mg protein, receptor co...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/9/2016
Entry Details
US Patent

TargetCannabinoid receptor 2(Human)
Allergan

US Patent
LigandChemical structure of BindingDB Monomer ID 163058BDBM163058(US9062004, 24 | US9670216, 24 2-t-Butyl-4-chloro--...)
Affinity DataIC50: 1.00E+4nMAssay Description:Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 .mu.mol/mg protein, receptor co...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/9/2016
Entry Details
US Patent

TargetCannabinoid receptor 2(Human)
Allergan

US Patent
LigandChemical structure of BindingDB Monomer ID 163059BDBM163059(US9062004, 25)
Affinity DataIC50: 1.00E+4nMAssay Description:Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 .mu.mol/mg protein, receptor co...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/9/2016
Entry Details
US Patent

TargetCannabinoid receptor 2(Human)
Allergan

US Patent
LigandChemical structure of BindingDB Monomer ID 163052BDBM163052(US9062004, 16)
Affinity DataIC50: 1.00E+4nMAssay Description:Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 .mu.mol/mg protein, receptor co...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/9/2016
Entry Details
US Patent

TargetCannabinoid receptor 2(Human)
Allergan

US Patent
LigandChemical structure of BindingDB Monomer ID 163053BDBM163053(US9062004, 17 | US9670216, 17 4-Chloro-5-dimethyla...)
Affinity DataIC50: 1.00E+4nMAssay Description:Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 .mu.mol/mg protein, receptor co...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/9/2016
Entry Details
US Patent

TargetCannabinoid receptor 2(Human)
Allergan

US Patent
LigandChemical structure of BindingDB Monomer ID 163054BDBM163054(US9062004, 18 | US9670216, 18 4-Chloro-2-(3,5-dime...)
Affinity DataIC50: 1.00E+4nMAssay Description:Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 .mu.mol/mg protein, receptor co...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/9/2016
Entry Details
US Patent

TargetCannabinoid receptor 2(Human)
Allergan

US Patent
LigandChemical structure of BindingDB Monomer ID 163055BDBM163055(US9062004, 20 | US9670216, 20 2-(3,5-Bistrifluorom...)
Affinity DataIC50: 1.00E+4nMAssay Description:Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 .mu.mol/mg protein, receptor co...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/9/2016
Entry Details
US Patent

TargetCannabinoid receptor 2(Human)
Allergan

US Patent
LigandChemical structure of BindingDB Monomer ID 163064BDBM163064(US9062004, 30 | US9670216, 30 2-Benzyl-4-chloro-5-...)
Affinity DataIC50: 1.00E+4nMAssay Description:Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 .mu.mol/mg protein, receptor co...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/9/2016
Entry Details
US Patent

TargetCannabinoid receptor 2(Human)
Allergan

US Patent
LigandChemical structure of BindingDB Monomer ID 163060BDBM163060(US9062004, 26 | US9670216, 26 4-Chloro-2-(2,5-dime...)
Affinity DataIC50: 1.00E+4nMAssay Description:Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 .mu.mol/mg protein, receptor co...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/9/2016
Entry Details
US Patent

TargetCannabinoid receptor 2(Human)
Allergan

US Patent
LigandChemical structure of BindingDB Monomer ID 163061BDBM163061(US9062004, 27 | US9670216, 27 2-t-Butyl-4-chloro-5...)
Affinity DataIC50: 1.00E+4nMAssay Description:Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 .mu.mol/mg protein, receptor co...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/9/2016
Entry Details
US Patent

TargetCannabinoid receptor 2(Human)
Allergan

US Patent
LigandChemical structure of BindingDB Monomer ID 163062BDBM163062(US9062004, 28 | US9670216, 28 4-Chloro-2-(3,5-dich...)
Affinity DataIC50: 1.00E+4nMAssay Description:Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 .mu.mol/mg protein, receptor co...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/9/2016
Entry Details
US Patent

TargetCannabinoid receptor 2(Human)
Allergan

US Patent
LigandChemical structure of BindingDB Monomer ID 163063BDBM163063(US9062004, 29 | US9670216, 29 4-Chloro-2-(2,5-dime...)
Affinity DataIC50: 1.00E+4nMAssay Description:Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 .mu.mol/mg protein, receptor co...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/9/2016
Entry Details
US Patent

TargetCannabinoid receptor 1(Human)
Allergan

US Patent
LigandChemical structure of BindingDB Monomer ID 163040BDBM163040(US9062004, 3 | US9670216, 3 4-Chloro-5-methylamino...)
Affinity DataIC50: 1.00E+4nMAssay Description:Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 .mu.mol/mg protein, receptor co...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/9/2016
Entry Details
US Patent

TargetCannabinoid receptor 1(Human)
Allergan

US Patent
LigandChemical structure of BindingDB Monomer ID 163043BDBM163043(US9062004, 6 | US9670216, 6 5-Methylamino-2-(3,3,5...)
Affinity DataIC50: 1.00E+4nMAssay Description:Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 .mu.mol/mg protein, receptor co...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/9/2016
Entry Details
US Patent

TargetCannabinoid receptor 1(Human)
Allergan

US Patent
LigandChemical structure of BindingDB Monomer ID 163039BDBM163039(US9062004, 2 | US9670216, 2 4,5-Dichloro-2-(3,3,5,...)
Affinity DataIC50: 1.00E+4nMAssay Description:Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 .mu.mol/mg protein, receptor co...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/9/2016
Entry Details
US Patent

TargetCannabinoid receptor 1(Human)
Allergan

US Patent
LigandChemical structure of BindingDB Monomer ID 163052BDBM163052(US9062004, 16)
Affinity DataIC50: 1.00E+4nMAssay Description:Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 .mu.mol/mg protein, receptor co...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/9/2016
Entry Details
US Patent

Displayed 1 to 50 (of 58 total ) | Next | Last >>
Jump to: